The prognostic value of PSA levels at 7-8 month

Yüksel Ürün shared a post on X:                     .

“PSA level of <0.2 ng/mL at months 7-8 is prognostic.

However, it is still unclear whether we can use this to guide treatment de-escalation or escalation. We need to wait for the results of ongoing studies to determine this. ”

Source: Yüksel Ürün/X

Dra. María Natalia Gandur Quiroga’s commented on Yüksel Ürün’s post:

“I agree with this statement. A PSA level of <0.2 ng/mL at months 7-8 is indeed prognostic. However, the clinical implications of using this metric to guide treatment de-escalation or escalation are still uncertain. We need to wait for the results of ongoing studies to better understand how to use this information in clinical practice. ”

Source: Dra. María Natalia Gandur Quiroga/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.

Maria Natalia Gandur Quiroga is a Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology at the Instituto de Oncología Ángel H. Roffo in Buenos Aires, Argentina. She is a Professor of Medicine at the University of Buenos Aires at the Oncologists Post Graduates Studies. Her research focuses on clinical trials with aims to improve the treatment of patients with urologic tumors.  She is an active member of the European Association for Cancer Research, Argentinian Medical Association and American Society of Clinical Oncology.